About Us - Committees - External Advisory Board

James L. Abbruzzese, MD - Bio and Pubs
Duke University School of Medicine

Dr. Abbruzzese is Chief of the Division of Medical Oncology and Associate Director for Clinical Research for the Duke Cancer Institute and Chair of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee. Dr. Abbruzzese joined Duke in November 2013 from M.D. Anderson Cancer Center, where he was chairman of the Department of Gastrointestinal Medical Oncology and Digestive Diseases and is a leading expert in the clinical study and treatment of pancreatic cancer.

Colin B Begg, PhD - Bio and Pubs
External Advisory Board

Dr. Begg is Attending Biostatistician and Chair of the Department of Epidemiology and Biostatistics at the Memorial Sloan-Kettering Cancer Center. Dr. Begg is a leading expert in biostatistical methods, clinical trials, and applications in cancer research.

Howard McLeod, PharmD - Bio and Pubs

Dr. McLeod is Cancer Research Chair, Medical Director of the DeBartolo Family Personalized Medicine Institute, and Senior Member in the Department of Cancer Epidemiology at Moffitt Cancer Center. Dr McLeod is an internationally recognized expert in pharmacogenomics and until joining Moffitt was the Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy and founding Director of the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at Chapel Hill. He is currently a member of the National Human Genome Research Institute Advisory Council.

Susan A Murphy, PhD - Bio and Pubs
Chair, External Advisory Board

Dr. Murphy is H. E. Robbins Professor of Statistics, Professor of Psychiatry, and Research Professor in the Institute for Social Research at the University of Michigan, and serves as Chair of the External Advisory Committee. Dr. Murphy is considered to be the foremost expert in biostatistical methods for sequential, multiple assignment, randomized trials (SMARTs) and discovery of dynamic treatment regimes. She is a 2013 MacArthur Foundation Fellow in recognition of her pioneering work in these areas.

Giovanni Parmigiani, PhD - Bio and Pubs
External Advisory Board

Dr. Parmigiani is Professor of Biostatistics at Harvard University and Chair of the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute. Dr. Parmigiani is an expert in Bayesian methods and one of the foremost biostatistical methodologists and practitioners in cancer clinical trials and cancer genomics.